224
Views
2
CrossRef citations to date
0
Altmetric
Systematic review and meta-analysis

Proportion of T follicular helper cells in peripheral blood of rheumatoid arthritis patients: a systematic review and meta-analysis

, , , ORCID Icon, , & show all
Pages 667-680 | Received 19 Dec 2020, Accepted 08 Apr 2021, Published online: 15 Apr 2021

References

  • Guo Q, Wang Y, Xu D, et al. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6(1):1–14.
  • Smolen JS, Aletaha D, Barton A, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018 [2018 Feb 08];4(1):18001.
  • Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038.
  • Chemin K, Gerstner C, Malmström V. Effector functions of CD4+ T cells at the site of local autoimmune inflammation—lessons from rheumatoid arthritis [review]. Front Immunol. 2019 [2019 Mar 12]; 10(353). 10.3389/fimmu.2019.00353
  • McHeyzer-Williams LJ, Pelletier N, Mark L, et al. Follicular helper T cells as cognate regulators of B cell immunity. Curr Opin Immunol. 2009;21(3):266–273.
  • Chtanova T, Tangye SG, Newton R, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol. 2004;173(1):68.
  • Breitfeld D, Ohl L, Kremmer E, et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med. 2000;192(11):1545–1552.
  • Schaerli P, Willimann K, Lang AB, et al. CXC chemokine receptor 5 expression defines follicular homing T cells with B cell helper function. J Exp Med. 2000;192(11):1553–1562.
  • Kim CH, Rott LS, Clark-Lewis I, et al. Subspecialization of CXCR5+ T cells: b helper activity is focused in a germinal center–localized subset of CXCR5+ T cells. J Exp Med. 2001;193(12):1373–1382.
  • Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29(1):621–663.
  • Linterman MA, Rigby RJ, Wong RK, et al. Follicular helper T cells are required for systemic autoimmunity. J Exp Med. 2009;206(3):561–576.
  • Behar SM, Lustgarten DL, Corbet S, et al. Characterization of somatically mutated S107 VH11-encoded anti-DNA autoantibodies derived from autoimmune (NZB x NZW)F1 mice. J Exp Med. 1991;173(3):731–741.
  • Diamond B, Katz JB, Paul E, et al. the role of somatic mutation in the pathogenic anti-DNA response. Annu Rev Immunol. 1992;10(1):731–757.
  • Yu D, Vinuesa CG. Multiple checkpoints keep follicular helper T cells under control to prevent autoimmunity. Cell Mol Immunol. 2010;7(3):198–203.
  • Morita R, Schmitt N, Bentebibel S-E, et al. Human blood CXCR5+ CD4+ T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011;34(1):108–121.
  • Simpson N, Gatenby PA, Wilson A, et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. 2010;62(1):234–244.
  • Gensous N, Charrier M, Duluc D, et al. T follicular helper cells in autoimmune disorders [Review]. Front Immunol. 2018;9(JUL). DOI:10.3389/fimmu.2018.01637.
  • Wells GA, Tugwell P, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2015.
  • Wan X, Wang W, Liu J, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014 [2014 Dec 19];14(1):135. .
  • Higgins J, Wells G. Cochrane handbook for systematic reviews of interventions. 2011. Available from: http://www.cochrane-handbook.org
  • Liu C, Wang D, Lu S, et al. Increased circulating follicular treg cells are associated with lower levels of autoantibodies in patients with rheumatoid arthritis in stable remission [Article]. Arthritis Rheumatol. 2018;70(5):711–721.
  • Ma J, Zhu C, Ma B, et al. Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis [Article]. Clin Dev Immunol. 2012;2012:1–7.
  • Han J, Zhou Q, Li X, et al. Novel function of hydroxychloroquine: Down regulation of T follicular helper cells in collagen-induced arthritis [Article]. Biomed Pharmacother. 2018;97:838–843.
  • An LM, Li J, Ji LL. et al. Detection of peripheral follicular helper T cells in rheumatoid arthritis [Article]. Beijing da xue xue bao Yi xue ban = J Peking Univ Health sci. 2016;48(6):951–957.
  • Takeshita M, Suzuki K, Kondo Y, et al. Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell [Article]. Ann Rheum Dis. 2019;78(10):1346–1356.
  • Wang J, Shan Y, Jiang Z, et al. High frequencies of activated B cells and T follicular helper cells are correlated with disease activity in patients with new-onset rheumatoid arthritis [Article]. Clin Exp Immunol. 2013;174(2):212–220.
  • Liu R, Wu Q, Su D, et al. A regulatory effect of IL-21 on T follicular helper-like cell and B cell in rheumatoid arthritis [Article]. Arthritis Res Therapy. 2012;14(6):6.
  • Cao G, Chi S, Wang X, et al. CD4+CXCR5+pd-1+ t follicular helper cells play a pivotal role in the development of rheumatoid arthritis [Article]. Med Sci Monit. 2019;25:3032–3040.
  • Wang X, Yang C, Xu F, et al. Imbalance of circulating Tfr/Tfh ratio in patients with rheumatoid arthritis [Article]. Clin Exp Med. 2019;19(1):55–64.
  • Zhang Y, Li Y, Lv TT, et al. Elevated circulating Th17 and follicular helper CD4+ T cells in patients with rheumatoid arthritis [Article]. APMIS. 2015;123(8):659–666.
  • Nakayamada S, Kubo S, Yoshikawa M, et al. Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis [Article]. Rheumatology (Oxford). 2018;57(1):164–174.
  • Fukuyo S, Nakayamada S, Iwata S, et al. Abatacept therapy reduces CD28+CXCR5+ follicular helper-like T cells in patients with rheumatoid arthritis [Article]. Clin Exp Rheumatol. 2017;35(4):562–570.
  • Chen XM, Li J, Zhang XY. et al. Significance of different T follicular helper subsets in rheumatoid arthritis [Article]. Beijing da xue xue bao Yi xue ban = J Peking Univ Health sci. 2016;48(6):958–963.
  • Costantino AB, Acosta CDV, Onetti L, et al. Follicular helper T cells in peripheral blood of patients with rheumatoid arthritis [Article]. Reumatol Clin. 2017;13(6):338–343.
  • He J, Tsai LM, Leong YA, et al. Circulating precursor CCR7loPD-1hi CXCR5+ CD4+ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure. Immunity. 2013;39(4):770–781.
  • Arroyo-Villa I, Bautista-Caro MB, Balsa A, et al. Constitutively altered frequencies of circulating follicullar helper T cell counterparts and their subsets in rheumatoid arthritis. Arthritis Res Ther. 2014 Dec 5;16(6):500.
  • Aldridge J, Pandya JM, Meurs L, et al. Sex-based differences in association between circulating T cell subsets and disease activity in untreated early rheumatoid arthritis patients. Arthritis Res Ther. 2018;20(1):150.
  • Umeda M, Koga T, Ichinose K, et al. CD4+ CD52lo T-cell expression contributes to the development of systemic lupus erythematosus [Article]. Clin Immunol. 2018;187:50–57.
  • Niu Q, Huang ZC, Wu XJ, et al. Enhanced IL-6/phosphorylated STAT3 signaling is related to the imbalance of circulating T follicular helper/T follicular regulatory cells in patients with rheumatoid arthritis [Article]. Arthritis Res Therapy. 2018;20(1):1.
  • Kang ZJ, Liu YQ, Zhang ZG, et al. Proportion of CCR7loPD-1hi follicular helper T cell in peripheral blood of systemic lupus erythematosus patients and its clinical role [Article]. Acad J Second Mil Med Univ. 2018;39(11):1202–1208.
  • Zhou H, Hu B, Zhaopeng Z, et al. Elevated circulating T cell subsets and cytokines expression in patients with rheumatoid arthritis [Article]. Clin Rheumatol. 2019;38(7):1831–1839.
  • Fortea-Gordo P, Nuno L, Villalba A, et al. Two populations of circulating PD-1hiCD4 T cells with distinct B cell helping capacity are elevated in early rheumatoid arthritis. Nat Immunol. 2019 Sep 1;58(9):1662–1673.
  • Penatti A, Facciotti F, De Matteis R, et al. Differences in serum and synovial CD4+ T cells and cytokine profiles to stratify patients with inflammatory osteoarthritis and rheumatoid arthritis [Article]. Arthritis Res Therapy. 2017;19(1):1.
  • Singh D, Henkel M, Sendon B, et al. Analysis of CXCR5+Th17 cells in relation to disease activity and TNF inhibitor therapy in rheumatoid arthritis [Article]. Sci Rep. 2016;6(1):39474.
  • Rao DA, Gurish MF, Marshall JL, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542(7639):110–114.
  • Yu D, Tan AH-M, Hu X, et al. Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA. Nature. 2007;450(7167):299–303.
  • Yao S, Chen LPD-1. as an immune modulatory receptor. Cancer J. 2014 Jul-Aug;20(4):262–264.
  • Good-Jacobson KL, Szumilas CG, Chen L, et al. PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells. Nat Immunol. 2010;11(6):535.
  • Choi J-Y, Ho JH-E, Pasoto SG, et al. Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol. 2015;67(4):988–999.
  • Liu C, Jiang J, Gao L, et al. Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways. Arthritis Res Ther. 2015;17(1):340.
  • Bauquet AT, Jin H, Paterson AM, et al. The costimulatory molecule ICOS regulates the expression of c-Maf and IL-21 in the development of follicular T helper cells and T H-17 cells. Nat Immunol. 2009;10(2):167.
  • Weber JP, Fuhrmann F, Feist RK, et al. ICOS maintains the T follicular helper cell phenotype by down-regulating Krüppel-like factor 2. J Exp Med. 2015;212(2):217–233.
  • Tahiliani V, Hutchinson TE, Abboud G, et al. OX40 cooperates with ICOS to amplify follicular th cell development and germinal center reactions during infection. J Immunol. 2017;198(1):218–228.
  • Zheng B, Xu G, Chen X, et al. ICOSL-mediated signaling is essential for the survival and functional maturation of germinal center B cells through the classical NF-κB pathway (IRM10P. 611). Am Assoc Immnol. 2015;194:131–139.
  • Rasheed AU, Rahn HP, Sallusto F, et al. Follicular B helper T cell activity is confined to CXCR5hiICOShi CD4 T cells and is independent of CD57 expression. Eur J Immunol. 2006;36(7):1892–1903.
  • Raza K, Falciani F, Curnow SJ, et al. Early rheumatoid arthritis is characterized by a distinct and transient synovial fluid cytokine profile of T cell and stromal cell origin. Arthritis Res Ther. 2005;7(4):R784–R795.
  • Zhou L, Jiang Y, Yan T, et al. The prognostic role of cancer stem cells in breast cancer: a meta-analysis of published literatures. Breast Cancer Res Treat. 2010 [2010 Aug 01];122(3):795–801.
  • Wan X, Luo X, Tan C, et al. First‐line atezolizumab in addition to bevacizumab plus chemotherapy for metastatic, nonsquamous non–small cell lung cancer: a United States–based cost‐effectiveness analysis. Cancer. 2019;125(20):3526–3534.
  • D’Andrea E, Kesselheim AS, Franklin JM, et al. Heterogeneity of antidiabetic treatment effect on the risk of major adverse cardiovascular events in type 2 diabetes: a systematic review and meta-analysis. Cardiovasc Diabetol. 2020 [2020 Sep 29];19(1):154.
  • Chen Y, Huang Y, Huang Y, et al. The prognostic value of SOX2 expression in non-small cell lung cancer: a meta-analysis. PloS One. 2013;8(8):e71140–e71140.
  • Zhang LW, Zhou PR, Wei P, et al. Expression of interleukin‐17 in primary Sjögren’s syndrome and the correlation with disease severity: a systematic review and meta‐analysis. Scand J Immunol. 2018;87(4):e12649.
  • Maceiras AR, Almeida SCP, Mariotti-Ferrandiz E, et al. T follicular helper and T follicular regulatory cells have different TCR specificity. Nat Commun. 2017;8(1):15067.
  • Liu X, Zhang W, Zhao M, et al. T cell receptor β repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis. Annals of the Rheumatic Diseases. 2019 Aug;78(8):1070–1078.
  • Kim SJ, Schätzle S, Ahmed SS, et al. Increased cathepsin S in Prdm1(-/-) dendritic cells alters the T(FH) cell repertoire and contributes to lupus. Nature Immunology. 2017 Sep;18(9):1016–1024.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.